Cargando…

Metabolic Profiling of Human In-patient Stools: The Influence of C. difficile Infection and Recurrence

BACKGROUND: Initial C. difficile infection (CDI) and recurrence is dependent on host susceptibility. Hospital patients have a diverse range of other comorbidities and concomitant medications that cannot be duplicated in animal models. We hypothesize that the intersection of the luminal biome and hos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yacyshyn, Mary Beth, Kukay, Jessica, Romick-Rosendale, Lindsey, Yacyshyn, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630917/ http://dx.doi.org/10.1093/ofid/ofx163.1592

Ejemplares similares

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy()
por: Yacyshyn, Mary Beth, et al.
Publicado: (2022)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018)

A Potential Biomarker for Acute Kidney Injury in Preterm Infants from Metabolic Profiling
por: Romick-Rosendale, Lindsey E., et al.
Publicado: (2012)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

Non-Targeted Metabolic Profiling of Cerebellum in Spina Bifida Fetal Rats
por: Thielen, Evan, et al.
Publicado: (2023)

Therapeutic Opportunities for Intestinal Angioectasia‐ Targeting PPARγ and Oxidative Stress
por: Sarangdhar, Mayur, et al.
Publicado: (2020)

Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD
por: Pippis, Elleni J, et al.
Publicado: (2020)

1626 The relationship of Bristol Stool Scale to Clostridium difficile infection
por: Caroff, Daniel, et al.
Publicado: (2014)

2236. Stool-Derived Inflammatory Mediators Serve as Biomarkers of Severity in Clostridium difficile Infection
por: Motyka, Jonathan, et al.
Publicado: (2019)

1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool
por: Bartolome, Amelita, et al.
Publicado: (2018)

532. Recurrent C. difficile in Children: Not Easy to Cure
por: Lee, Philip, et al.
Publicado: (2018)

Rate of Detection of Multiple Organisms and Clostridium difficile with Stool Multiplex PCR Detection Test in Pediatrics
por: Mangla, Saisho, et al.
Publicado: (2017)

Canonical Wnt Signaling Ameliorates Aging of Intestinal Stem Cells
por: Nalapareddy, Kodandaramireddy, et al.
Publicado: (2017)

Feasibility Study of NMR Based Serum Metabolomic Profiling to Animal Health Monitoring: A Case Study on Iron Storage Disease in Captive Sumatran Rhinoceros (Dicerorhinus sumatrensis)
por: Watanabe, Miki, et al.
Publicado: (2016)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

1088. Ultrasensitive Detection of C. difficile Toxins in Stool Using Single Molecule Counting Technology: A Multicenter Study for Evaluation of Clinical Performance
por: Young, Stephen, et al.
Publicado: (2018)

1657 Who Seeks a Fecal Microbiota Transplant for Recurrent C. difficile Infection?: Patient Profile of the PUNCH CD Study
por: Orenstein, Robert, et al.
Publicado: (2014)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

Performance of chromID Clostridium difficile Agar Compared with BBL C. difficile Selective Agar for Detection of C. difficile in Stool Specimens
por: Han, Sang Bong, et al.
Publicado: (2014)

Lung Metabolomics Profiling of Congenital Diaphragmatic Hernia in Fetal Rats
por: Romero-Lopez, Maria del Mar, et al.
Publicado: (2021)

663. Epidemiology and outcomes of recurrent C. difficile infection among hematopoietic cell transplant recipients
por: Sanchez, Eduardo, et al.
Publicado: (2023)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

Enzyme Immunoassay for C. difficile Toxin Reduces Lab ID Events but Fails to Detect Clinically Significant C. difficile Infection
por: Ridgway, Jessica P, et al.
Publicado: (2017)

Therapeutic reduction of lysophospholipids in the digestive tract recapitulates the metabolic benefits of bariatric surgery and promotes diabetes remission
por: Cash, James G., et al.
Publicado: (2018)

2010. Volatile Organic Compounds Patterns in Breath, Plasma, and Stool in Patients with Clostridium difficile Infection: A Cross-Sectional Proof of Concept Study
por: John, Teny Mathew, et al.
Publicado: (2018)

2567. Effect of Broad vs. Narrow-Spectrum Clostridioides difficile Treatment on Human Stool Bile Acid Composition Over Time
por: Thorpe, Cheleste M, et al.
Publicado: (2019)

Genome Wide Analysis Reveals Host Genetic Variants that Associate with Reduction in Clostridium difficile Infection Recurrence (rCDI) in Patients Treated with Bezlotoxumab
por: Shaw, Peter, et al.
Publicado: (2017)

Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS)
por: Dorr, Mary Beth, et al.
Publicado: (2017)

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
por: Matrka, Marie C., et al.
Publicado: (2017)

2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019)

Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2021)

Erratum: Romero-Lopez et al. Lung Metabolomics Profiling of Congenital Diaphragmatic Hernia in Fetal Rats. Metabolites 2021, 11, 177
por: Romero-Lopez, Maria del Mar, et al.
Publicado: (2021)

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
por: Vickers, Richard J, et al.
Publicado: (2017)

Risk Factors for Recurrent Pedatric Community Associated Clostridium difficile Infection
por: Parmar, Deepika, et al.
Publicado: (2017)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

2387. Learning the Influence of Individual Clostridioides difficile Infections
por: Mu, Emily, et al.
Publicado: (2019)

2578. Narrow-Spectrum Antibiotic Treatment of Clostridium difficile Infection Improves Preservation of Intestinal Metabolic Profile
por: Park, Seoyoung, et al.
Publicado: (2019)

Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens
por: Shin, Bo-Moon, et al.
Publicado: (2016)

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iaa69kvufqim4n3etk347vo2dr